Krishna Institute of Medical Sciences Limited Share Price

Equities

KIMS

INE967H01017

Healthcare Facilities & Services

Market Closed - NSE India S.E. 12:43:52 13/05/2024 BST 5-day change 1st Jan Change
1,970 INR -1.41% Intraday chart for Krishna Institute of Medical Sciences Limited -4.22% -0.45%

Financials

Sales 2024 * 25.23B 302M 24.08B Sales 2025 * 29.81B 357M 28.45B Capitalization 158B 1.89B 150B
Net income 2024 * 3.38B 40.53M 3.23B Net income 2025 * 4.14B 49.61M 3.95B EV / Sales 2024 * 6.52 x
Net Debt 2024 * 6.83B 81.85M 6.52B Net Debt 2025 * 6.95B 83.28M 6.63B EV / Sales 2025 * 5.52 x
P/E ratio 2024 *
47.3 x
P/E ratio 2025 *
39.3 x
Employees 4,588
Yield 2024 *
0.29%
Yield 2025 *
0.41%
Free-Float 53.71%
More Fundamentals * Assessed data
Dynamic Chart
Krishna Institute of Medical Sciences Buys Land For New Hospital in Thane, India MT
Krishna Institute of Medical Sciences Plans INR5 Billion Investment to Build Hospital in Thane, India MT
Krishna Institute of Medical Sciences Limited Enters into Definitive Agreements for Taking Land on A 99-Year Lease and Purchase of Building for the Setting Up of New Hospital At Thane CI
Krishna Institute of Medical Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Krishna Institute of Medical Sciences Limited Announces Cessation of Rajeswara Rao Gandu as Independent Director CI
Krishna Institute of Medical Sciences Limited acquired 5.04% stake in KIMS-SUNSHINE Hospitals for INR 740 million. CI
Krishna Institute of Medical Sciences Limited Announces Ceasation of Pankaj Vaish as Independent Director CI
BCAL Diagnostics Joins Forces to Conduct Breast Cancer Blood Test Study in India MT
Krishna Institute of Medical Sciences Limited Appoints Adwik Bollineni as Additional Director CI
Krishna Institute Of Medical Sciences Reports Decline in Fiscal Q2 Consolidated Net Profit MT
Krishna Institute of Medical Sciences Limited Announces Resignation of Shantanu Rastogi as Non-Executive & Non-Independent Director CI
Krishna Institute of Medical Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Krishna Institute of Medical Sciences Acquires Additional Stake in Subsidiary MT
Krishna Institute of Medical Sciences Limited acquired an additional 6.86% in Spanv Medisearch Lifesciences Private Limited for INR 270 million CI
Krishna Institute of Medical Sciences Acquires Additional 5.7% Stake in SPANV Medisearch MT
More news
1 day-1.41%
1 week-4.22%
Current month-3.10%
1 month-0.39%
3 months-9.79%
6 months+5.50%
Current year-0.45%
More quotes
1 week
1 960.00
Extreme 1960
2 073.40
1 month
1 908.00
Extreme 1908
2 105.80
Current year
1 885.55
Extreme 1885.55
2 356.40
1 year
1 493.95
Extreme 1493.95
2 356.40
3 years
937.55
Extreme 937.55
2 356.40
5 years
937.55
Extreme 937.55
2 356.40
10 years
937.55
Extreme 937.55
2 356.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 36 31/12/14
Director of Finance/CFO - 31/07/23
Chairman 70 11/11/02
Members of the board TitleAgeSince
Director/Board Member 62 07/01/21
Director/Board Member 70 18/05/22
Chairman 70 11/11/02
More insiders
Date Price Change Volume
13/05/24 1,970 -1.41% 12,867
10/05/24 1,998 -0.06% 46,404
09/05/24 2,000 -1.30% 43,556
08/05/24 2,026 -1.58% 72,515
07/05/24 2,059 +0.07% 143,459

Delayed Quote NSE India S.E., May 13, 2024 at 12:43 pm

More quotes
Krishna Institute of Medical Sciences Ltd is an India-based company that is principally engaged in the business of rendering medical and healthcare services. The Company’s departments include accident, Alzheimer center, andrology and infertility center, pediatric obesity, pediatric oncology, pediatric oncology and hematology center, pediatric orthopedics and rheumatology, pediatric renal center, pediatric surgical center, female urology center, fertility center, gastrointestinal oncology, general surgery, heart wellness center and hepatobiliary surgery center. Its technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, EBUS, Spy Glass, Mako Robotic for Knee Replacement, and Impella. The Company’s institutes include the institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, and Institute of Neuro Sciences.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,970 INR
Average target price
2,310 INR
Spread / Average Target
+17.24%
Consensus